API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
51
PharmaCompass offers a list of Bifonazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bifonazole manufacturer or Bifonazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bifonazole manufacturer or Bifonazole supplier.
PharmaCompass also assists you with knowing the Bifonazole API Price utilized in the formulation of products. Bifonazole API Price is not always fixed or binding as the Bifonazole Price is obtained through a variety of data sources. The Bifonazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole, including repackagers and relabelers. The FDA regulates (+-)-1-(p,alpha-Diphenylbenzyl)imidazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+-)-1-(p,alpha-Diphenylbenzyl)imidazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole supplier is an individual or a company that provides (+-)-1-(p,alpha-Diphenylbenzyl)imidazole active pharmaceutical ingredient (API) or (+-)-1-(p,alpha-Diphenylbenzyl)imidazole finished formulations upon request. The (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers may include (+-)-1-(p,alpha-Diphenylbenzyl)imidazole API manufacturers, exporters, distributors and traders.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole DMF (Drug Master File) is a document detailing the whole manufacturing process of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole active pharmaceutical ingredient (API) in detail. Different forms of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole DMFs exist exist since differing nations have different regulations, such as (+-)-1-(p,alpha-Diphenylbenzyl)imidazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole DMF submitted to regulatory agencies in the US is known as a USDMF. (+-)-1-(p,alpha-Diphenylbenzyl)imidazole USDMF includes data on (+-)-1-(p,alpha-Diphenylbenzyl)imidazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (+-)-1-(p,alpha-Diphenylbenzyl)imidazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The (+-)-1-(p,alpha-Diphenylbenzyl)imidazole Drug Master File in Japan ((+-)-1-(p,alpha-Diphenylbenzyl)imidazole JDMF) empowers (+-)-1-(p,alpha-Diphenylbenzyl)imidazole API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the (+-)-1-(p,alpha-Diphenylbenzyl)imidazole JDMF during the approval evaluation for pharmaceutical products. At the time of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers with JDMF on PharmaCompass.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP of the European Pharmacopoeia monograph is often referred to as a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole Certificate of Suitability (COS). The purpose of a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole to their clients by showing that a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP has been issued for it. The manufacturer submits a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP holder for the record. Additionally, the data presented in the (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (+-)-1-(p,alpha-Diphenylbenzyl)imidazole DMF.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers with CEP (COS) on PharmaCompass.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole written confirmation ((+-)-1-(p,alpha-Diphenylbenzyl)imidazole WC) is an official document issued by a regulatory agency to a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole manufacturer, verifying that the manufacturing facility of a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting (+-)-1-(p,alpha-Diphenylbenzyl)imidazole APIs or (+-)-1-(p,alpha-Diphenylbenzyl)imidazole finished pharmaceutical products to another nation, regulatory agencies frequently require a (+-)-1-(p,alpha-Diphenylbenzyl)imidazole WC (written confirmation) as part of the regulatory process.
click here to find a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole suppliers with Written Confirmation (WC) on PharmaCompass.
(+-)-1-(p,alpha-Diphenylbenzyl)imidazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+-)-1-(p,alpha-Diphenylbenzyl)imidazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+-)-1-(p,alpha-Diphenylbenzyl)imidazole GMP manufacturer or (+-)-1-(p,alpha-Diphenylbenzyl)imidazole GMP API supplier for your needs.
A (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CoA (Certificate of Analysis) is a formal document that attests to (+-)-1-(p,alpha-Diphenylbenzyl)imidazole's compliance with (+-)-1-(p,alpha-Diphenylbenzyl)imidazole specifications and serves as a tool for batch-level quality control.
(+-)-1-(p,alpha-Diphenylbenzyl)imidazole CoA mostly includes findings from lab analyses of a specific batch. For each (+-)-1-(p,alpha-Diphenylbenzyl)imidazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+-)-1-(p,alpha-Diphenylbenzyl)imidazole may be tested according to a variety of international standards, such as European Pharmacopoeia ((+-)-1-(p,alpha-Diphenylbenzyl)imidazole EP), (+-)-1-(p,alpha-Diphenylbenzyl)imidazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+-)-1-(p,alpha-Diphenylbenzyl)imidazole USP).